Search market news

Roche to Present Lung and Breast Cancer Data at ESMO 2026

Roche said it will present late-stage trial results at the ESMO 2026 cancer meeting in Madrid, including data on divarasib and giredestrant.

Roche to Present Late-Stage Lung and Breast Cancer Data at ESMO 2026

Roche to Present Cancer Data at ESMO 2026

Roche says it will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the meeting in Madrid from Oct. 23 to 27.

Genentech to Present Late-Stage Cancer Data at ESMO 2026

Genentech says it will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the ESMO annual meeting in Madrid from October 23 to 27.

Transcript: Iovance Biotherapeutics Q2 2026 Earnings Conference Call

Iovance Biotherapeutics (NASDAQ: IOVA ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call

Pfizer to present 45 oncology abstracts at ESMO 2026

Pfizer said it will present data from 45 company-sponsored, investigator-sponsored and collaborative research abstracts at the European Society for Medical Oncology congress in Madrid, Spain, on Oct. 23-27, 2026.

BeiGene Reports Q2 2026 Results: Full Earnings Call Transcript

BeiGene (NASDAQ: ONC ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary BeiGene reported strong Q2 2026 financial results with $1.7 billion in t